Home
StockRanks™
Platform
Insights
Research & Discuss
Editorial & Community
Learn & Improve
Webinars & Masterclasses
Stockopedia Academy
Reviews
Pricing
Get started
Log in
Sectors
Healthcare
Pharmaceuticals
Apellis Pharmaceuticals
APLS —
Apellis Pharmaceuticals
News Story
$41.03
0.00
0.00%
Last trade -
00:00
Healthcare
Adventurous
Large Cap
High Flyer
Market Cap
$5.25bn
Enterprise Value
$5.30bn
Revenue
$1.00bn
Quality
Value
Momentum
Stock
Rank
™
StockReport™
Accounts
Balance sheet
Income statement
Cashflow statement
Dividend summary
News
APLS Dividends
StockReport™
Balance sheet
Income statement
Cashflow
News
APLS Dividends
All News
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
Apellis Pharmaceuticals
14/05/2026 08:58
NASDAQ TRADE HALT APLS.O REASON NOT AVAILABLE AT 03:58 AM
Recent news on Apellis Pharmaceuticals
See all news
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
14/05/2026 08:58
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
14/05/2026 24:50
Citi, Truist trim PT on Biogen ahead of Q1 earnings
13/04/2026 15:36
Deals of the day-Mergers and acquisitions
01/04/2026 14:42
Street View: Biogen's $5.6 billion Apellis bet a strategic fit
01/04/2026 12:31